21.90MMarket Cap-1369P/E (TTM)
16.5900High15.8500Low2.79KVolume15.8500Open16.7747Pre Close44.50KTurnover0.37%Turnover RatioLossP/E (Static)1.32MShares22.320052wk High1.35P/B12.59MFloat Cap6.200052wk Low--Dividend TTM758.84KShs Float780.0000Historical High--Div YieldTTM4.41%Amplitude6.2000Historical Low15.9550Avg Price1Lot Size
Pieris Pharmaceuticals Stock Forum
3 MINUTES AGO, 7:30 AM EDT
VIA GLOBENEWSWIRE
FDA Orphan Products Grants are based on scientific and technical merit as determined by rare disease and regulatory experts
Ongoing Phase 3 trial evaluating QTORIN™ 3.9% rapamycin...
PRNewswire 24-Jul-2024 2:55 PM
This firm never misses a merger! Dont know if they do good work on not but Damn! Its every one! Hehehe
$Pieris Pharmaceuticals (PIRS.US)$
No comment yet